Centrum Zdrowia Alcea
- Address
- lock Available on a paid plan
Centrum Zdrowia Alcea - Depression and Sleep Disorder Research
Centrum Zdrowia Alcea is a specialized clinical research facility focused on psychiatric conditions and sleep-related disorders. The center demonstrates particular expertise in studying complex mental health presentations where mood disorders intersect with sleep disturbances, contributing to the development of novel therapeutic approaches for patients with treatment-resistant conditions.
- Major Depressive Disorder with comorbid insomnia symptoms
- Adjunctive pharmacotherapy for treatment-resistant depression
- Long-term efficacy and safety studies of novel antidepressant combinations
- Relapse prevention strategies in psychiatric disorders
The research center actively participates in advanced clinical trials evaluating innovative treatment regimens for patients with inadequate response to standard antidepressant therapy, particularly examining selective serotonin and serotonin-norepinephrine reuptake inhibitor combinations. Their research methodology encompasses both short-term efficacy assessment and extended safety monitoring, providing comprehensive data on emerging psychiatric medications and their role in managing depression with concurrent sleep difficulties.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Zdrowia Alcea
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder with Insomnia Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study | Janssen Cilag International | Phase III | Recruiting | Mar 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| SELTOREXANT | 1 | Unknown | 2025-03-18 | 2025-03-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.